Maribavir - CAS 176161-24-3

Maribavir (GW257406X) is an orally available benzimidazole riboside compound with activity against cytomegalovirus (CMV) . Maribavir is a selective ATP competitor of the viral UL97 kinase, which is involved in viral nuclear maturation events, such as viral DNA assembly and movement of viral capsids from the nucleus of infected cells. Maribavir has activity against strains of CMV that are resistant to standard anti-CMV agents.

Antifection, HCV Protease, Virus Protease

Microbiology/Virology, Proteases/Proteasome

176134

>99.99%

C15H19Cl2N3O4

376.24

CC(C)Nc1nc2cc(Cl)c(Cl)cc2n1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O

-20°C

Ice Packs

Small Compound